BMEA - NASDAQ

Biomea Fusion, Inc.

Biomea Fusion, Inc.

BMEA·NASDAQ

$1.38

+6.2%
HealthcareBiotechnology

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$82.10M
EPS-1.1800
P/E Ratio-1.17
Earnings Date08/03/2026

bmea

Additional Paid-In Capital

Last Annual Value

478.59M

3-Year CAGR

26%

5-Year CAGR

105%

10-Year CAGR

67%

Biomea Fusion, Inc.

Biomea Fusion, Inc. Competitors Analysis of Additional Paid-In Capital

BMEA · NASDAQ
CompanyAdditional Paid-In Capital
CAGR 3Y
CAGR 5Y
CAGR 10Y
BMEA logo
Biomea Fusion, Inc.
NASDAQ:BMEA
478.59M
4.6%15.9%N/A 
GUTS logo
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS
565.72M
197.2%110.3%N/A
IMUX logo
Immunic, Inc.
NASDAQ:IMUX
599.24M
11.2%13.1%7.1%
PMVP logo
PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
551.08M
1.0%3.0%N/A
ACET logo
Adicet Bio, Inc.
NASDAQ:ACET
773.79M
12.0%10.4%N/A
ATYR logo
aTyr Pharma, Inc.
NASDAQ:ATYR
673.55M
6.4%6.9%9.2%
PLRX logo
Pliant Therapeutics, Inc.
NASDAQ:PLRX
1.04B
2.3%20.2%N/A
SRZN logo
Surrozen, Inc.
NASDAQ:SRZN
339.52M
9.4%6.1%N/A
ZNTL logo
Zentalis Pharmaceuticals, Inc.
NASDAQ:ZNTL
1.41B
2.1%14.2%N/A
SPRB logo
Spruce Biosciences, Inc.
NASDAQ:SPRB
331.75M
6.6%9.1%N/A
ADVM logo
Adverum Biotechnologies, Inc.
NASDAQ:ADVM
1.14B
4.3%3.4%10.7%
Biomea Fusion, Inc.

Biomea Fusion, Inc. Fair Value Envelope

BMEA · NASDAQ

Our analysis suggests that BMEA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.38, this represents a potential HIDDEN relative to our calculated worth for Biomea Fusion, Inc..

HIDDEN
Intrinsic Value
Current Price: $1.38

Related Guides

Blog Categories

Continue your BMEA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.